Nature reviews. Gastroenterology & hepatology. 2025 Jun 11. doi: 10.1038/s41575-025-01091-7 Q151.02025

Head-to-head trial of HCV treatment regimens

丙肝治疗方案的对照临床试验 翻译改进

作者单位 +展开

DOI: 10.1038/s41575-025-01091-7 PMID: 40500468

摘要 中英对照阅读

Copyright © Nature reviews. Gastroenterology & hepatology. 中文内容为AI机器翻译，仅供参考！

相关内容

• Danoprevir: First Global Approval

  丹诺previr：第一个全球批准

  Anthony Markham

  Drugs. 2018 Aug;78(12):1271-1276.

• A sprint to increase response to HCV treatment: expectancies but caution

  迈向丙型肝炎治疗响应提速之路：期待与谨慎并存

  Tarik Asselah

  Journal of hepatology. 2011 Nov;55(5):1154-8.

• Methadone and HCV treatment

  美沙酮与丙肝治疗

  P A McCormick et al.

  Irish medical journal. 2008 Nov-Dec;101(10):316-7.

• Outcomes of HCV treatment: who does well and who does not?

  HCV治疗的效果：哪些患者有效以及为何有效？

  Ching-Sheng Hsu

  Journal of gastroenterology and hepatology. 2010 May;25(5):846-8.

• Sofosbuvir: a new milestone in HCV treatment?

  索夫布韦：丙型肝炎治疗的新进展？

  Katherine Smith

  Nature reviews. Gastroenterology & hepatology. 2013 May;10(5):258.

• Sofosbuvir, a Significant Paradigm Change in HCV Treatment

  索夫布韦在丙型肝炎治疗中具有里程碑意义的变革作用

  Thomas McQuaid

  Journal of clinical and translational hepatology. 2015 Mar;3(1):27-35.

• Realize the advance in HCV treatment, but remain cautious

  实现HCV治疗的进步，但仍需谨慎

  Tarik Asselah

  Journal of hepatology. 2011 Dec;55(6):1457-60.

• Clinical trial on a new combination of hepatoprotecting agents

  新的肝保护剂组合的临床试验

  M Barlattani

  Arzneimittel-Forschung. 1970 Apr;20(4):560-5.

• STAR*D: the results begin to roll in

  明星(D)研究开始出成果了

  Matthew Menza

  The American journal of psychiatry. 2006 Jul;163(7):1123.